Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Curtis J. Scheel | M | 63 |
NorWesTech, Inc.
 NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 6 years |
| Paul G. Kanan | M | 78 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 15 years |
| Stanley L. Schloz | M | 79 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 4 years |
| Ellen Rudnick | F | 73 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 6 years |
| Fred Burstein | M | 88 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 1 years |
| Tonya K. Aggoune | F | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 15 years |
| John P. Jensen | M | 68 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 6 years |
| Andrew Ecclestone | M | 61 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 1 years |
| Kenneth R. Waters | M | 73 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 9 years |
| Ronald R. Helm | M | 73 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 9 years |
| Elizabeth Teng Leary | M | 76 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 23 years |
| Mario R. Ehlers | M | 65 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 9 years |
| Richard W. Palfreyman | M | 82 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 9 years |
| Edwin Merrifield | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 5 years |
| Amar A. Sethi | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Peter Ludlum | M | 68 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 3 years |
| Jason Ray | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 9 years |
| Sheri DuMond | F | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Patrick Jackle | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Sana Sakr | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Richard J. Gordon | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Dorota Schranz | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 7 years |
| Kristin H. Walsh | F | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Michael Carrosino | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Janice E. O'Connor | F | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Terry M. Giles | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | - |
| Michael P. Murphy | M | 70 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 13 years |
| Timothy Carlson | M | - |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dave Swezey
- Personal Network
